Measurement of Anti-S Protein IgG4 Antibody and IgY Antibody Treatment Begins in

  • Measurement of Anti-S Protein IgG4 Antibody and IgY Antibody Treatment Begins in

    Posted by 福田 克彦 on February 20, 2024 at 5:31 pm EST

    <font _mstmutation=”1″ _msttexthash=”17782241191″ _msthash=”3765″>I am the first M.D. Ph.D. in Japan to advocate COVID-19 vaccine sequelae, and I have treated over 1500 cases of mRNA PVS to date. Although the 7th SAS-CoV2 mRNA vaccine has been introduced in Japan, we are in the midst of the 10th wave of infection, and the use of mornupiravir is the highest in the world. The drug risks increasing the incidence of mutant strains of the replicon-type vaccine, which is currently being tested on thousands of Japanese. This autologous vaccine has been shown to produce IgG4 antibodies at lower levels than previous mRNA vaccines. We have begun measuring anti-S protein IgG4 antibodies and are investigating the increase in IgG4 antibody titers with each cumulative booster dose, and have begun inhalation therapy with omicron mutant derived IgY antibodies that may be effective against the current JN-1 pandemic. We plan to stockpile tens of millions of chicken egg-derived IgY antibody inhalers in preparation for the next coming “vaccine pandemic=Vaccidemic”.</font>

    福田 克彦 replied 1 year ago 1 Member · 0 Replies
  • 0 Replies

Sorry, there were no replies found.

Log in to reply.